The gene CA8 (carbonic anhydrase 8) is mapped to human chromosome 8q. It is an isozyme of a-carbonic anhydrases and is widely expressed. However, it is strongly expressed in the cerebellum. The protein does not exhibit catalytic carbonic anhydrase activity.
Synonyms: Anti-CA-VIII; Anti-CARP; Anti-Carbonic anhydrase VIII; Anti-Carbonic anhydrase-related protein
Storage: -20C
Application: All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project (www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry. The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit sigma.com/prestige.
Biochem Physiol Actions: Mutations in CA8 (carbonic anhydrase 8) gene causes neuropathology, such as ataxia, mild mental retardation and the predisposition to quadrupedal gait. It is also associated with the development of colorectal and lung cancers. Additionally, it is upregulated in various cancers.
Legal Information: Prestige Antibodies is a registered trademark of Sigma-Aldrich Co. LLC